Back
Cardiol Therapeutics, Inc. Stock Predictions
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
50
CRDL
Cardiol Therapeutics, Inc.
Last Price:
$1.02
Seasonality Move:
5.49%
7 Day Trial
ALL ACCESS PASS
$
7
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiCardiol Therapeutics, Inc. Stock Forecast
-
Is Cardiol Therapeutics, Inc. Stock Undervalued?The current Cardiol Therapeutics, Inc. [CRDL] share price is $1.01. The Score for CRDL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
CRDL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Cardiol Therapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
Cardiol Therapeutics, Inc. Stock Rating
Data Unavailable
Cardiol Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Canada
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
cardiolrx.com
52-Week Data
52-Week High:
1.59
52-Week Low:
0.77
Prediction Charts
Market Cap:
101M
Price in USD:
1.01
Volume:
277K
Beta:
1.18
Technical Analysis
SMA50:
1.05
SMA100:
1.09
SMA200:
1.14
52-Wk Change:
-22.9%
Stock Predictions
-
Is Cardiol Therapeutics, Inc. stock public?Yes, Cardiol Therapeutics, Inc. is a publicly traded company.
-
What is the Cardiol Therapeutics, Inc. stock quote today?The Cardiol Therapeutics, Inc. stock price is 1.01 USD today.
-
How to buy Cardiol Therapeutics, Inc. stock online?You can buy Cardiol Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 1.01 | 0.93 | 1.02 | 0.90 |
| Dec-3 | 0.91 | 0.94 | 0.97 | 0.88 |
| Dec-4 | 0.95 | 0.96 | 0.99 | 0.92 |
| Dec-5 | 0.95 | 1.05 | 1.06 | 0.95 |
| Dec-8 | 1.04 | 1.00 | 1.06 | 0.99 |
| Dec-9 | 1.03 | 1.08 | 1.09 | 1.01 |
| Dec-10 | 1.07 | 1.08 | 1.12 | 1.05 |
| Dec-11 | 1.08 | 1.09 | 1.10 | 1.07 |
| Dec-12 | 1.11 | 1.08 | 1.11 | 1.06 |
| Dec-15 | 1.11 | 1.03 | 1.11 | 1.01 |
| Dec-16 | 1.02 | 1.04 | 1.05 | 1.01 |
| Dec-17 | 1.04 | 1.00 | 1.05 | 1.00 |
| Dec-18 | 1.01 | 1.01 | 1.03 | 1.00 |
| Dec-19 | 1.00 | 1.01 | 1.02 | 1.00 |
Cardiol Therapeutics, Inc. Earnings
Data Unavailable
Cardiol Therapeutics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.04 per share.
* Cardiol Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.